Published in Br J Pharmacol on August 01, 1994
Gαq G proteins modulate MMP-9 gelatinase during remodeling of the murine femoral artery. J Surg Res (2012) 0.80
Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol (1978) 13.02
The smooth muscle cell in culture. Physiol Rev (1979) 5.03
Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res (1988) 3.71
Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest (1989) 2.10
Culture of quiescent arterial smooth muscle cells in a defined serum-free medium. J Cell Physiol (1983) 2.03
Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature (1991) 1.83
Angiotensin II induces c-fos mRNA in aortic smooth muscle. Role of Ca2+ mobilization and protein kinase C activation. J Biol Chem (1989) 1.83
Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun (1989) 1.79
Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension (1989) 1.75
Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest (1993) 1.66
Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther (1990) 1.57
Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp Mol Pathol (1981) 1.56
Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2). J Pharmacol Exp Ther (1990) 1.50
Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research. Hypertension (1991) 1.48
Subclasses of angiotensin II binding sites and their functional significance. Mol Pharmacol (1990) 1.48
Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension (1991) 1.46
Nonpeptide angiotensin II receptor antagonists. Trends Pharmacol Sci (1991) 1.45
Molecular cloning, sequence analysis and expression of a cDNA encoding human type-1 angiotensin II receptor. Biochem Biophys Res Commun (1992) 1.37
Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells. Am J Physiol (1989) 1.25
Angiotensin II receptor subtypes in cultured rat renal mesangial cells. Am J Physiol (1992) 1.18
Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype. J Med Chem (1991) 1.15
Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats. J Hypertens (1990) 1.06
Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension (1990) 1.04
Analysis of the evolution of angiotensin II type 1 receptor gene in mammals (mouse, rat, bovine and human). Biochem Biophys Res Commun (1992) 1.03
Receptor-mediated effects of angiotensin II on growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension (1992) 1.03
Angiotensin II induces expression of the c-fos gene through protein kinase C activation and calcium ion mobilization in cultured vascular smooth muscle cells. Biochem Biophys Res Commun (1988) 1.03
Molecular cloning and sequencing of the gene encoding human angiotensin II type 1 receptor. Biochem Biophys Res Commun (1992) 0.97
Angiotensin II receptor subtypes: characterization, signalling mechanisms, and possible physiological implications. Front Neuroendocrinol (1993) 0.96
Binding characteristics and vascular effects of various angiotensin II antagonists. J Cardiovasc Pharmacol (1990) 0.95
Mitogenic action of interleukin-1 alpha on vascular smooth muscle cells mediated by PDGF. Atherosclerosis (1990) 0.94
Cloning, expression and regulation of angiotensin II receptors. J Hypertens (1992) 0.90
Angiotensin II-1 receptors mediate both vasoconstrictor and hypertrophic responses in rat aortic smooth muscle cells. Receptor (1991) 0.89
A novel angiotensin receptor subtype in rat mesangium. Coupling to adenylyl cyclase. Hypertension (1993) 0.86
Cloning, expression, and characterization of a gene encoding the human angiotensin II type 1A receptor. Biochem Biophys Res Commun (1992) 0.86
A recombinant rat vascular AT1 receptor confers growth properties to angiotensin II in Chinese hamster ovary cells. Biochem Biophys Res Commun (1992) 0.84
Angiotensin II and noradrenaline increase PDGF-BB receptors and potentiate PDGF-BB stimulated DNA synthesis in vascular smooth muscle. Biochem Biophys Res Commun (1990) 0.82
Potent, orally active imidazo[4,5-b]pyridine-based angiotensin II receptor antagonists. J Med Chem (1991) 0.81
Mitogenesis in cultured vascular smooth muscle cells from two rat models of hypertension in response to fetal calf serum and angiotensin II. J Cardiovasc Pharmacol (1990) 0.78
Molecular cloning of AT1 angiotensin receptors. Am J Hypertens (1992) 0.78
Localization of angiotensin II receptor subtypes in the rabbit adrenal and kidney. Peptides (1991) 0.77
Platelet-derived growth factor (PDGF) accelerates induction of competence, and heparin does not inhibit PDGF-induced competence in primary cultured smooth muscle cells of rat aorta. Jpn J Pharmacol (1992) 0.76
Identification of a fourth angiotensin AT1 receptor subtype in rat. Biochem Biophys Res Commun (1993) 0.76
North-South twinning in paediatric haemato-oncology: the La Mascota programme, Nicaragua. Lancet (1998) 1.75
Is there a benefit of frequent CT follow-up after EVAR? Eur J Vasc Endovasc Surg (2009) 1.59
Treatment of childhood Hodgkin's disease with COPP or COPP-ABV (hybrid) without radiotherapy in Nicaragua. Ann Oncol (1997) 1.58
Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart (2005) 1.57
Weight growth in infants born to mothers who smoked during pregnancy. BMJ (1995) 1.25
Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients. Anticancer Res (2001) 1.13
Impact of nutrition on pharmacokinetics of anti-neoplastic agents. Int J Cancer Suppl (1998) 1.04
Kissing stents in the aortic bifurcation--a valid reconstruction for aorto-iliac occlusive disease. Eur J Vasc Endovasc Surg (2008) 0.96
Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line. Nutr Cancer (1997) 0.93
Interaction between neurons in different laminae of the dorsal horn of the spinal cord. A correlation study in normal and neuropathic rats. Eur J Neurosci (1997) 0.89
Synthesis and SAR of 3- and 4-substituted quinolin-2-ones: discovery of mixed 5-HT(1B)/5-HT(2A) receptor antagonists. Bioorg Med Chem (2001) 0.89
Frequency-dependence of serotonin autoreceptor but not alpha 2-adrenoceptor inhibition of [3H]-serotonin release in rat hypothalamic slices. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.86
Telling young children with leukemia their diagnosis: the flower garden as analogy. Pediatr Hematol Oncol (1994) 0.86
Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus. J Pharmacol Exp Ther (1985) 0.85
Studies on the serotonin transporter in platelets. Experientia (1988) 0.85
A study of early ongoing activity in dorsal horn units following sciatic nerve constriction. Neuroreport (1994) 0.84
A locus on 15q15-15qter influences dyslexia: further support from a transmission/disequilibrium study in an Italian speaking population. J Med Genet (2004) 0.84
Presynaptic alpha 2-adrenoceptor antagonism by verapamil but not by diltiazem in rabbit hypothalamic slices. Br J Pharmacol (1983) 0.84
Poststimulus afterdischarges of spinal WDR and NS units in rats with chronic nerve constriction. Neuroreport (1995) 0.84
Interaction between neuronal uptake inhibitors and presynaptic serotonin autoreceptors in rat hypothalamic slices: comparison of K+ and electrical depolarization. J Pharmacol Exp Ther (1987) 0.82
Evidence that exogenous but not endogenous norepinephrine activates the presynaptic alpha-2 adrenoceptors on serotonergic nerve endings in the rat hypothalamus. J Pharmacol Exp Ther (1984) 0.81
Long-term progression of contralateral carotid artery disease after endarterectomy: is there a need for Duplex surveillance? Int Angiol (2012) 0.80
Presynaptic inhibition by dopamine receptor agonists of noradrenergic neurotransmission in the rabbit hypothalamus. J Pharmacol Exp Ther (1982) 0.80
Inhibition by 5,6-dihydroxy-2-dimethylaminotetralin (M7) of noradrenergic neurotransmission in the rabbit hypothalamus: role of alpha-2 adrenoceptors and of dopamine receptors. J Pharmacol Exp Ther (1985) 0.80
Interaction between serotonin uptake inhibitors and alpha-2 adrenergic heteroreceptors in the rat hypothalamus. J Pharmacol Exp Ther (1990) 0.80
Amphetamine inhibits the electrically evoked release of [3H]dopamine from slices of the rabbit caudate. J Pharmacol Exp Ther (1983) 0.79
[Rehabilitation of deafness in the elderly: multidisciplinary intervention in experimental university center]. Acta Otorhinolaryngol Ital (1996) 0.78
High resolution scanning electron microscopy of the intracellular surface of intercalated disks in human heart. Tissue Cell (2006) 0.78
[3H]Imipramine binding and [3H]5HT uptake in human blood platelets: changes after one week chlorimipramine treatment. Eur J Pharmacol (1984) 0.78
Changes in [3H]5-HT uptake and [3H]imipramine binding in platelets after chlorimipramine in healthy volunteers. Comparison with maprotiline and amineptine. Biol Psychiatry (1987) 0.77
Diurnal variation in the function of serotonin terminals in the rat hypothalamus. J Neurochem (1989) 0.77
Functional characterization of alpha-1-adrenoceptor subtypes in the prostatic urethra and trigone of male rabbit. J Pharmacol Exp Ther (1996) 0.76
Efficacy and tolerability of moclobemide in bulimia nervosa: a placebo-controlled trial. Int Clin Psychopharmacol (2001) 0.76
SL 84.0418: a novel, potent and selective alpha-2 adrenoceptor antagonist: in vitro pharmacological profile. J Pharmacol Exp Ther (1992) 0.76
Antidepressant-binding sites in brain and platelets. Ciba Found Symp (1986) 0.75
[3H]Imipramine is accumulated but not released from slices of the rabbit caudate and hypothalamus. J Neurochem (1982) 0.75
Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors. Psychopharmacology (Berl) (1986) 0.75
Long-term progression of contralateralcarotid artery disease after endarterectomy: is there a need for Duplex surveillance? Int Angiol (2014) 0.75
Lack of seasonal variation in platelet [3H]imipramine binding in humans. Biol Psychiatry (1986) 0.75
The prognostic significance of clinical history, exercise testing and ambulatory electrocardiography in patients with uncomplicated myocardial infarction. G Ital Cardiol (1985) 0.75
Ischemia without symptoms after saphenous and mammary graft failure: palliation with coronary angioplasty? Cardiologia (1988) 0.75
[Physiological and pharmacological importance of presynaptic beta-adrenoceptors in modulation of noradrenaline release]. Therapie (1983) 0.75
Effect of liposome-encapsulated alpha- or beta-interferon on breast cancer cell lines. Anticancer Res (1998) 0.75
Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression. J Recept Res (1987) 0.75
[Detection with the Holter method of asymptomatic arrhythmias and silent ischemias in myocardial infarct patients transferred from the coronary unit]. Boll Soc Ital Cardiol (1980) 0.75
Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol. J Pharmacol Exp Ther (1983) 0.75
Platelet 3H-imipramine binding and steroid hormones serum concentrations during the menstrual cycle. Psychopharmacology (Berl) (1986) 0.75
[Blood pressure during exercise stress in young normal subjects with familial hypertension (author's transl)]. G Ital Cardiol (1981) 0.75
[Comparative evaluation of different kits for serum digoxin determination (author's transl)]. G Ital Cardiol (1980) 0.75
Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups. Blood Cancer J (2014) 0.75
[Retrospective analysis in patients hospitalized in a coronary unit for acute myocardial infarct]. Minerva Cardioangiol (1981) 0.75
Pharmacological characterization of a specific binding site for angiotensin IV in cultured porcine aortic endothelial cells. Eur J Pharmacol (1996) 0.75
Short-term lithium administration to healthy volunteers produces long-lasting pronounced changes in platelet serotonin uptake but not imipramine binding. Psychopharmacology (Berl) (1988) 0.75
Light-dark differences in [3H]-paroxetine binding to rabbit platelet membranes. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.75
Phorbol-12,13-dibutyrate antagonizes while forskolin potentiates the presynaptic autoreceptor-mediated inhibition of [3H]-5-hydroxytryptamine release in rat hypothalamic slices. Synapse (1989) 0.75
[Echocardiographic diagnosis of rupture of the interventricular septum and release into the wall of the left ventricle (with formation of pseudoaneurysm) in inferior myocardial infarction]. Cardiologia (1990) 0.75
[False echocardiographic images of an atrial thrombus in pericarditis]. Cardiologia (1988) 0.75
[Evaluation of the usefulness of hospitalization in the coronary unit of aged patients with acute myocardial infarct]. Minerva Cardioangiol (1981) 0.75
Methiothepin enhances the potassium-evoked release of [3H]-noradrenaline in rat pineal gland. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.75
Pitfalls in demonstrating an endogenous ligand of imipramine recognition sites. Biochem Pharmacol (1987) 0.75
Involvement of adenylate cyclase and protein kinase C in the alpha 2-adrenoceptor-mediated inhibition of noradrenaline and 5-hydroxytryptamine release in rat hypothalamic slices. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.75
Diabetes mellitus and lifestyle in a north Italian population. Diabetes Res Clin Pract (1990) 0.75
Potentiation by deprenyl of the autoreceptor-mediated inhibition of [3H]-5-hydroxytryptamine release by 5-methoxytryptamine. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.75
[Clinical significance of the determination of lidocaine and anti-arrhythmic drugs in acute myocardial infarct]. Minerva Cardioangiol (1981) 0.75